AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
Portfolio Pulse from
AngioDynamics (ANGO) reported a Q2 loss of $0.04 per share, which was better than the Zacks Consensus Estimate of a $0.11 loss. This is an improvement from the $0.05 loss per share reported a year ago.
January 08, 2025 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AngioDynamics reported a Q2 loss of $0.04 per share, better than the expected $0.11 loss, showing improvement from last year's $0.05 loss.
The better-than-expected earnings report is likely to have a positive short-term impact on AngioDynamics' stock price. The company reported a smaller loss than anticipated, which is a positive signal to investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100